MedTrace Logo

Safety Study of a Bioresorbable Coronary Stent

NCT01262703 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2023-03-29

No results posted yet for this study

Summary

To evaluate the safety of a new bioresorbable (non-permanent) stent platform in native coronary arteries.

Conditions

Interventions

DEVICE

ReZolve Stent

ReZolve Sirolimus-Eluting Bioresorbable Coronary Stent

Sponsors & Collaborators

  • REVA Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Alexandre Abizaid, MD · Instituto Dante Pazzanese de Cardiologia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-10-31
Completion
2018-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01262703 on ClinicalTrials.gov